window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : October 4, 2025

  • News
  • About Us
Contact Us

real-world data

  • Artificial Intelligence,Clinical Trials,Digital Health,Drug Development,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Technology and platforms

    QuantHealth secures strategic investment from Sanofi Ventures to accelerate AI-driven clinical trials

    QuantHealth, a pioneer in AI-driven clinical trial simulation, has received [...]

    October 1, 2025
  • Chronic diseases,Data Management,Drug Development,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    New Phesi data shows more than 100 diseases being studied with GLP-1 therapies

    Analysis highlights potential for benefits far beyond obesity, signalling a [...]

    September 12, 2025
  • Artificial Intelligence,Clinical Development,Global health,Patient Centricity,Real world evidence,Research & Development

    Briya launches clinical-grade AI assistant for accelerating medical and epidemiological research

    New AI platform designed to support faster discovery, better study [...]

    August 1, 2025
  • Artificial Intelligence,Data Management,Patient Centricity,Precision medicine,Real world evidence,Research & Development

    OMNY Health dataset surpasses 100M patients, creating largest US repository of unstructured clinical data

    OMNY Health has reached a major milestone, announcing that its [...]

    July 31, 2025
  • Clinical Development,Global health,Patient Centricity,Real world evidence,Research & Development,Technology and platforms

    Cytovale’s IntelliSep test drives 56% rise in safe ED discharges, easing pressure on hospital beds

    A new multicenter study has found that a rapid blood [...]

    July 28, 2025
  • Artificial Intelligence,Drug Development,Partnerships & Funding,Research & Development

    AI-powered initiative in Louisiana aims to accelerate ALS drug discovery

    A new AI-led collaboration is being launched to advance drug [...]

    July 23, 2025
  • Artificial Intelligence,Clinical Trials,Drug Development,Real world evidence,Research & Development

    QuantHealth clinical trial simulations deliver $31.4m savings and 90% accuracy

    QuantHealth has simulated more than 350 clinical trials using its [...]

    July 23, 2025
  • Artificial Intelligence,Partnerships & Funding,Patient Centricity,Technology and platforms

    Sorcero acquires Axiom Health to unify AI insights across pharma and medtech

    Sorcero MedTech launch enables single AI platform for drug and [...]

    July 16, 2025
  • Drug Delivery & Formulation,Drug Development,Patient Centricity

    Most people with HIV choose long-acting injectables over daily pills

    Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]

    July 15, 2025
  • Clinical Development,Clinical Trials,Patient Centricity

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    July 10, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2025 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • HeliosX strengthens leadership team to drive global growth and brand innovation
    Categories: Digital Health, Global health, Market Access & Commercialization, Movers & Shakers, Patient Centricity, Pharmaceuticals and therapeutics, Technology and platforms
  • SeaBeLife secures €2 million to advance dual-targeted therapies for dry AMD and severe acute hepatitis
    Categories: Biotech, Clinical Development, Clinical Trials, Drug Development, Global health, Partnerships & Funding, Rare Diseases, Research & Development
  • Amorphical reports positive interim results from ongoing Crohn’s disease trial
    Categories: Chronic diseases, Clinical Development, Clinical studies, Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top